Reproducibility means obtaining consistent results by repeating an analysis with the same documented models, datasets, preprocessing, parameters, and procedures. In end-to-end drug-discovery pipelines, it requires managing versions across every component. section 13.4.3
A reproducible analysis records:
- The version of every component model, including changes in training data, architecture, or hyperparameters. section 13.4.3
- The training datasets, preprocessing pipelines, and inference parameters used to produce results. section 13.4.3
- End-to-end validation, because errors can propagate through cascaded structure-prediction and docking models. section 13.4.3
Changing a model version
An analysis run with ESM-2 version 1.0 may produce different results from the same analysis run with version 2.0. Reproduction therefore requires preserving the model version, training data, preprocessing, and inference settings rather than recording only the final output. section 13.4.3










